(RDY) Dr. Reddy’s - Performance 17% in 12m

RDY performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.

Performance Rating 29.83%
#38 in Peer-Group
Rel. Strength 67.21%
#2495 in Stock-Universe
Total Return 12m 17.02%
#46 in Peer-Group
Total Return 5y 71.55%
#24 in Peer-Group
P/E Value
P/E Trailing 20.2
P/E Forward 19.3
High / Low USD
52 Week High 16.84 USD
52 Week Low 12.36 USD
Sentiment Value
VRO Trend Strength +-100 86.03
Buy/Sell Signal +-5 -1.42
Support / Resistance Levels
Support
Resistance
12m Total Return: RDY (17%) vs XLV (-5.1%)
Total Return of Dr. Reddy’s versus its related sector ETF XLV
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (RDY) Dr. Reddy’s - Performance 17% in 12m

Top Performer in Pharmaceuticals

Short Term Performance

Symbol 1w 1m 3m
RDY 1.09% 9.8% 19.5%
PHAT 20.5% 206% 120%
VTYX 0.0% 112% 81.6%
ALTS 3.27% 64.1% 127%

Long Term Performance

Symbol 6m 12m 5y
RDY 7.56% 17% 71.6%
ALTS 172% 335% 234%
VRNA 116% 453% 1,673%
BGM 57.0% 276% -72.2%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
CORT NASDAQ
Corcept Therapeutics
-4.5% 145% 360% 61.3 55.3 0.61 23.7% -5.15%
LLY NYSE
Eli Lilly
12% -6.78% 514% 66.1 37 1.24 58.2% 18.9%
NVS NYSE
Novartis
10.1% 17.9% 81.6% 18.5 14 1.37 8.70% 9.2%
NOVN SW
Novartis
7.55% 7.58% 54.8% 18.7 14.1 1.38 9.80% 11.2%
SFZN SW
Siegfried Holding
-0.63% 2.28% 140% 26.1 25 1.48 77.8% 77.6%
GSK NYSE
GlaxoSmithKline
10% 4.92% 57.7% 19.9 9.2 0.4 -25.2% 3.11%
AZN NASDAQ
AstraZeneca
9.51% -4.27% 58.6% 28.9 15.9 0.96 52.7% 22.3%
IPN PA
Ipsen
2.14% -13% 54.2% 24.4 10.3 0.74 -6.40% -6.33%

Performance Comparison: RDY vs XLV vs S&P 500

XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for RDY
Total Return (including Dividends) RDY XLV S&P 500
1 Month 9.80% 4.35% 1.11%
3 Months 19.52% -6.89% 5.58%
12 Months 17.02% -5.08% 10.51%
5 Years 71.55% 50.53% 109.12%

Trend Score (consistency of price movement) RDY XLV S&P 500
1 Month 90.1% 65.8% 69.9%
3 Months 85.6% -72% 69.3%
12 Months -52.4% -62.2% 43.2%
5 Years 61.8% 88.5% 84.1%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XLV vs. S&P 500
1 Month #63 5.23% 8.60%
3 Month #41 28.36% 13.20%
12 Month #47 23.28% 5.89%
5 Years #27 13.96% -17.96%

FAQs

Does Dr. Reddy’s (RDY) outperform the market?

Yes, over the last 12 months RDY made 17.02%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%. Over the last 3 months RDY made 19.52%, while XLV made -6.89%.

Performance Comparison RDY vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

RDY vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 1.5% 8.7% 8.6% 7%
US NASDAQ 100 QQQ 1.8% 8.3% 9.3% 8%
German DAX 40 DAX 3.8% 10.6% -7.8% -12%
Shanghai Shenzhen CSI 300 CSI 300 1.8% 10.7% 6.7% 5%
Hongkong Hang Seng HSI 1% 4.8% -10.5% -10%
India NIFTY 50 INDA 3.3% 11.1% 9.6% 19%
Brasil Bovespa EWZ -0.8% 9.3% -11.6% 8%

RDY vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 1.9% 8.3% 5.8% -6%
Consumer Discretionary XLY 2.1% 11.6% 18.4% -1%
Consumer Staples XLP 1.9% 10% 7.1% 10%
Energy XLE -4.3% 6.9% 5% 14%
Financial XLF 3.1% 12.4% 5.7% -7%
Health Care XLV -0.4% 5.5% 9% 22%
Industrial XLI 2.6% 9.5% 3% -1%
Materials XLB 2.2% 8.4% 7.8% 18%
Real Estate XLRE 1% 8.8% 7.6% 4%
Technology XLK 1.2% 7.8% 8.2% 13%
Utilities XLU 0.2% 9.3% 0.2% -4%
Aerospace & Defense XAR 2.5% 4% -8.4% -26%
Biotech XBI 1.9% 2% 19.3% 25%
Homebuilder XHB 3.2% 14.8% 24% 26%
Retail XRT 5.5% 10% 16.5% 16%

RDY vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -10.3% -8.89% -1.29% 14%
Natural Gas UNG 2.3% 12.4% -9.7% 32%
Gold GLD -2.1% 3.6% -21.6% -30%
Silver SLV 2.4% -1.6% -11% -5%
Copper CPER 4.1% 8.1% -6.3% 9%

RDY vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 0.1% 9.1% 10% 21%
iShares High Yield Corp. Bond HYG 1.1% 9.3% 4.9% 8%